Our novel RNA therapeutics target the endocannabinoid and energy expenditure systems, promoting the browning of white fat to increase metabolism and facilitate sustainable weight loss. Unlike conventional approaches, our therapies prioritize the preservation of lean body mass and offer the convenience of less frequent dosing, making them a promising solution for individuals battling difficult-to-treat obesity and its associated metabolic complications.
Company Details
- Employees
- 20
- Founded
- -
- Address
- 5063 North Service Road, Burlington,on L7l 5h6,canada
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- canaryhealthtech.com
- Keywords
- Road.
- HQ
- Burlington, ON
Canary Cure Therapeutics Questions
Canary Cure Therapeutics's website is canaryhealthtech.com
Canary Cure Therapeutics's LinkedIn profile is https://ca.linkedin.com/company/canaryglobal
Canary Cure Therapeutics has
20 employees.
View email and phone details for 20
employees at Canary Cure Therapeutics.
Canary Cure Therapeutics's industry is
Biotechnology Research
Canary Cure Therapeutics's top competitors are
Aspect Biosystems,
Alpha-9 Oncology,
Thoucentric,
Wrig Nanosystems,
Ibm,
Cognitensor,
Zymeworks Inc.,
Canary Global Inc,
Kaggle,
Bpl Medical Technologies.
Canary Cure Therapeutics's categories are Biotechnology Research
Canary Cure Therapeutics's founding year is 2018
